Autopsy report · NCT02160535

Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA

“Study discontinued due to difficulty in enrolling eligible subjects”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 3 months before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 2 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University of Washington

Sponsor type

University, hospital or other

Conditions

Chronic Post Traumatic Headache

Interventions

OnabotulinumtoxinA

Participants

13

Sites

1

Countries

United States

Trials that died the same way

• LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
  “Study was discontinued due to slow enrollment” (84% match in meaning)
• Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast
  “Study discontinued due to lack of subject follow-up.” (81% match in meaning)
• Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease
  “The study was withdrawn due to not being able to recruit subjects.” (81% match in meaning)
• Salvage Cryotherapy in Recurrent Prostate Cancer
  “Study was ended due to low enrollment” (79% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.